References | A psychological intervention by community pharmacies to prevent depression in adults with subthreshold depression and long-term conditions: the CHEMIST pilot RCT

A psychological intervention by community pharmacies to prevent depression in adults with subthreshold depression and long-term conditions: the CHEMIST pilot RCT · References

References

World Health Organization (WHO). The Global Burden of Disease: 2004 Update. Geneva: WHO; 2008.
Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long Term Conditions and Mental Health: The Cost of Co-morbidities. London: The King’s Fund and Centre for Mental Health; 2012.
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851–8. 10.1016/S0140-6736(07)61415-917826170
Mercer SW, Watt GC. The inverse care law: clinical primary care encounters in deprived and affluent areas of Scotland. Ann Fam Med 2007;5:503–10. 10.1370/afm.77818025487
Mujica-Mota RE, Roberts M, Abel G, Elliott M, Lyratzopoulos G, Roland M, Campbell J. Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. Qual Life Res 2015;24:909–18. 10.1007/s11136-014-0820-725344816
NHS England and Public Health England. Five Year Forward View. URL: www.england.nhs.uk/ourwork/futurenhs/5yfv-fore/ (accessed 30 October 2019).
Naylor C, Das P, Ross S, Honeyman M, Thompson J, Gilburt H. Bringing Together Physical and Mental Health. London: The King’s Fund and Centre for Mental Health; 2016.
NHS. The NHS Long Term Plan. URL: www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf (accessed 30 October 2019).
Cuijpers P, de Graaf R, van Dorsselaer S. Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. J Affect Disord 2004;79:71–9. 10.1016/S0165-0327(02)00348-815023482
National Collaborating Centre for Mental Health, National Institute for Health Clinical Excellence, British Psychological Society, Royal College of Psychiatrists. Common Mental Health Disorders: Identification and Pathways to Care. London: RCPsych Publications; 2011.
Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured both. Br J Psychiatry 2013;202:22–7. 10.1192/bjp.bp.112.11216923284149
Rodríguez MR, Nuevo R, Chatterji S, Ayuso-Mateos JL. Definitions and factors associated with subthreshold depressive conditions: a systematic review. BMC Psychiatry 2012;12:181. 10.1186/1471-244X-12-18123110575
National Institute for Health and Care Excellence (NICE). Depression in Adults with a Chronic Physical Health Problem. Clinical Guidance [CG91]. London: NICE; 2009.
McManus S, Meltzer H, Brugha T, Bebbington P, Jenkins R. Adult Psychiatric Morbidity in England 2007: Results of a Household Survey. Leeds: NHS Digital; 2009.
Dowrick C, Chew-Graham C, Lovell K, Lamb J, Aseem S, Beatty S, et al. Increasing equity of access to high-quality mental health services in primary care: a mixed-methods study. Programme Grants Appl Res 2013;1(2). 10.3310/pgfar01020
Pharmaceutical Services Negotiating Committee. About Community Pharmacy. URL: https://psnc.org.uk/psncs-work/about-community-pharmacy/ (accessed 30 October 2019).
Todd A, Copeland A, Husband A, Kasim A, Bambra C. The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open 2014;4:e005764. 10.1136/bmjopen-2014-005764
Todd A, Copeland A, Husband A, Kasim A, Bambra C. Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation. BMJ Open 2015;5:e007328. 10.1136/bmjopen-2014-007328
Lindsey L, Husband A, Steed L, Walton R, Todd A. Helpful advice and hidden expertize: pharmacy users’ experiences of community pharmacy accessibility. J Public Health 2017;39:609–15. 10.1093/pubmed/fdw089
Knox K, Kelly F, Mey A, Hattingh L, Fowler JL, Wheeler AJ. Australian mental health consumers’ and carers’ experiences of community pharmacy service. Health Expect 2015;18:2107–20. 10.1111/hex.1217924612376
Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health 2011;11:582. 10.1186/1471-2458-11-58221777456
Steed L, Kassavou K, Madurasinghe VW, Edwards EA, Todd A, Summerbell CD, et al. Community pharmacy interventions for health promotion: effects on professional practice and health outcomes (Protocol). Cochrane Database Syst Rev 2014;7:CD011207. 10.1002/14651858.CD011207
Pharmaceutical Services Negotiating Committee. PSNC Briefing 026/19: A Summary of the Five-Year Deal on the Community Pharmacy Contractual Framework. URL: https://psnc.org.uk/wp-content/uploads/2019/07/PSNC-Briefing-026.19-A-Summary-of-the-Five-Year-Deal-on-the-Community-Pharmacy-Contractual-Framework.pdf (accessed 30 October 2019).
Department of Health and Social Care, NHS England and NHS Improvement, Pharmaceutical Services Negotiating Committee. The Community Pharmacy Contractual Framework for 2019/20 to 2023/24: Supporting Delivery for the NHS Long Term Plan. URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/819601/cpcf-2019-to-2024.pdf (accessed 3 February 2020).
Pharmaceutical Services Negotiating Committee. PSNC Healthy Living Pharmacies. URL: https://psnc.org.uk/services-commissioning/locally-commissioned-services/healthy-living-pharmacies/ (accessed 30 October 2019).
Thomson K, Hillier-Brown F, Walton N, Bilaj M, Bambra C, Todd A. The effects of community pharmacy-delivered public health interventions on population health and health inequalities: a review of reviews. Prev Med 2019;124:98–109. 10.1016/j.ypmed.2019.04.00330959070
Patel C, North F, Head J, et al. The Marmot Review. Fair Society, Healthy Lives: Strategic Review of Health Inequalities in England Post-2010. London: University College London; 2010.
NHS Confederation. Health on the High Street: Rethinking the Role of Community Pharmacy. London: NHS Confederation; 2013.
Smith SM, Wallace E, O’Dowd T, Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev 2016;3:CD006560. 10.1002/14651858.CD006560.pub3
van Zoonen K, Buntrock C, Ebert DD, Smit F, Reynolds CF, Beekman AT, Cuijpers P. Preventing the onset of major depressive disorder: a meta-analytic review of psychological interventions. Int J Epidemiol 2014;43:318–29. 10.1093/ije/dyt17524760873
Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1998;1:2.10345255
Gunn J, Diggens J, Hegarty K, Blashki G. A systematic review of complex system interventions designed to increase recovery from depression in primary car. BMC Health Serv Res 2006;6:88. 10.1186/1472-6963-6-8816842629
Gilbody S, Bower P, Fletcher J, Richards D, Sutton A. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 2006;166:2314–21. 10.1001/archinte.166.21.231417130383
Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA 2003;289:3145–51. 10.1001/jama.289.23.314512813120
Archer J, Bower P, Gilbody S, Lovell K, Richards D, Gask L, et al. Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev 2012;10:CD006525. 10.1002/14651858.CD006525.pub2
Ekers D, Murphy R, Archer J, Ebenezer C, Kemp D, Gilbody S. Nurse-delivered collaborative care for depression and long-term physical conditions: a systematic review and meta-analysis. J Affect Disord 2013;149:14–22. 10.1016/j.jad.2013.02.03223545062
Mitchell N, Hewitt C, Adamson J, Parrott S, Torgerson D, Ekers D, et al. A randomised evaluation of CollAborative care and active surveillance for Screen-Positive EldeRs with sub-threshold depression (CASPER): study protocol for a randomized controlled trial. Trials 2011;12:225. 10.1186/1745-6215-12-22521988800
Gilbody S, Lewis H, Adamson J, Atherton K, Bailey D, Birtwistle J, et al. Effect of collaborative care vs usual care on depressive symptoms in older adults with subthreshold depression: the CASPER randomized clinical trial. JAMA 2017;317:728–37. 10.1001/jama.2017.013028241357
Kingstone T, Bartlam B, Burroughs H, Bullock P, Lovell K, Ray M, et al. Can support workers from AgeUK deliver an intervention to support older people with anxiety and depression? A qualitative evaluation. BMC Fam Pract 2019;20:16. 10.1186/s12875-019-0903-130660195
Kingstone T, Burroughs H, Bartlam B, Ray M, Proctor J, Shepherd T, et al. Developing a community-based psycho-social intervention with older people and third sector workers for anxiety and depression: a qualitative study. BMC Fam Pract 2017;18:77. 10.1186/s12875-017-0648-728701184
Gilbody S, Bower P, Whitty P. Costs and consequences of enhanced primary care for depression: systematic review of randomised economic evaluations. Br J Psychiatry 2006;189:297–308. 10.1192/bjp.bp.105.01600617012652
Sampson SJ, Todd A, Walton N, Steele R, Webster L, Churchill R, et al. Pharmacy based management for depression in adults. Cochrane Database Syst Rev 2019;4:CD013299. 10.1002/14651858.CD013299
Brown JVE, Walton N, Meader N, Todd A, Webster LA, Steele R, et al. Pharmacy-based management for depression in adults. Cochrane Database Syst Rev 2019;12:CD013299. 10.1002/14651858.CD013299.pub2
Littlewood E, Ali S, Badenhorst J, Bailey D, Bambra C, Chew-Graham C, et al. Community Pharmacies Mood Intervention Study (CHEMIST): feasibility and external pilot randomised controlled trial protocol. Pilot Feasibility Stud 2019;5:71. 10.1186/s40814-019-0457-y31161045
May C, Finch T. Implementing, embedding, and integrating practices: an outline of normalization process theory. Sociology 2009;43:535–54. 10.1177/0038038509103208
Ritchie J, Spencer L. Qualitative Data Analysis for Applied Policy Research. London: Routledge; 1994. pp. 173–94. 10.4324/9780203413081_chapter_9
Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res 2017;17:88. 10.1186/s12913-017-2031-828126032
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl. 20):22–33.
Department of Health and Social Care. Improving the Health and Well-being of People with Long-term Conditions. World Class Services for People with Long-term Conditions – Information Tool for Commissioners. London: Department of Health and Social Care; 2010.
NHS England. 2019/20 General Medical Services (GMS) Contract Quality and Outcomes Framework (QOF). London: NHS England; 2019.
Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997;12:439–45. 10.1046/j.1525-1497.1997.00076.x9229283
National Institute for Care Excellence (NICE). Management of Depression in Primary and Secondary Care. London: NICE; 2009.
American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders (4th edition, text revision). Washington, DC: APA; 2000.
World Health Organization (WHO). ICD-10: International Statistical Classification of Diseases and Related Health Problems. Tenth Revision. 2nd edn. Geneva: WHO; 2004.
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014;348:g1687. 10.1136/bmj.g168724609605
Overend K, Lewis H, Bailey D, Bosanquet K, Chew-Graham C, Ekers D, et al. CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial. Trials 2014;15:451. 10.1186/1745-6215-15-45125409776
Martell CR, Dimidjian S, Herman-Dunn R. Behavioral Activation for Depression: A Clinician’s Guide. New York, NY: Guilford Press; 2013.
Pasterfield M, Bailey D, Hems D, McMillan D, Richards D, Gilbody S. Adapting manualized behavioural activation treatment for older adults with depression. Cogn Behav Ther 2014;7:E5. 10.1017/S1754470X14000038
Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 2005;44:227–39. 10.1348/014466505X2965716004657
Page AC, Hooke GR, Morrison DL. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in depressed clinical samples. Br J Clin Psychol 2007;46:283–97. 10.1348/014466506X15899617697478
Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, et al. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive–compulsive disorder: the Obsessive–Compulsive Treatment Efficacy randomised controlled Trial (OCTET). Health Technol Assess 2017;21(37). 10.3310/hta21370
Manos RC, Kanter JW, Luo W. The behavioral activation for depression scale–short form: development and validation. Behav Ther 2011;42:726–39. 10.1016/j.beth.2011.04.00422036000
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13. 10.1046/j.1525-1497.2001.016009606.x11556941
Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM. Br J Gen Pract 2007;57:650–2.17688760
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092–7. 10.1001/archinte.166.10.109216717171
Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258–66. 10.1097/00006842-200203000-0000811914441
Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33. 10.1097/00005650-199603000-000038628042
EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208. 10.1016/0168-8510(90)90421-910109801
Glaser BG. The constant comparative method of qualitative analysis. Soc Probl 1965;12:436–45. 10.2307/798843
Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ 2015;350:h1258. 10.1136/bmj.h125825791983
Mulhern B, Mukuria C, Barkham M, Knapp M, Byford S, Soeteman D, Brazier J. Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D. Br J Psychiatry 2014;205:236–43. 10.1192/bjp.bp.112.12228324855127
Byford S, Harrington R, Torgerson D, Kerfoot M, Dyer E, Harrington V, et al. Cost-effectiveness analysis of a home-based social work intervention for children and adolescents who have deliberately poisoned themselves. Results of a randomised controlled trial. Br J Psychiatry 1999;174:56–62. 10.1192/bjp.174.1.5610211152
Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095–108. 10.1097/00005650-199711000-000029366889
Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004;42:851–9. 10.1097/01.mlr.0000135827.18610.0d15319610
Chew-Graham CA, Kitchen CEW, Gascoyne S, Littlewood E, Coleman E, Bailey D, et al. The feasibility and acceptability of a brief psychological intervention for adults with long-term health conditions and subthreshold depression delivered via community pharmacies: a mixed methods evaluation – the Community Pharmacies Mood Intervention Study (CHEMIST). Pilot Feasibility Stud 2022;8:27. 10.1186/s40814-022-00992-735115052
Richards DA, Hill JJ, Gask L, Lovell K, Chew-Graham C, Bower P, et al. Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ 2013;347:f4913. 10.1136/bmj.f491323959152
Murray E, Treweek S, Pope C, MacFarlane A, Ballini L, Dowrick C, et al. Normalisation process theory: a framework for developing, evaluating and implementing complex interventions. BMC Med 2010;8:63. 10.1186/1741-7015-8-6320961442
Kraemer H, Wilson G, Fairburn CG, Agras W. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002;59:877–83. 10.1001/archpsyc.59.10.87712365874
Department of Health and Social Care (DHSC). NHS Reference Costs 2017/18. URL: https://improvement.nhs.uk/resources/reference-costs/ (accessed 30 October 2019).
Curtis L, Burns A. Unit Costs of Health and Social Care 2017. Canterbury: Personal Social Services Research Unit, University of Kent; 2017.
May C, Rapley T, Mair FS, Treweek S, Murray E, Ballini L, et al. Normalization Process Theory On-Line Users’ Manual, Toolkit and Nomad Instrument. URL: www normalizationprocess.org (accessed 27 August 2020).
May CR, Cummings A, Girling M, Bracher M, Mair FS, May CM, et al. Using normalization process theory in feasibility studies and process evaluations of complex healthcare interventions: a systematic review. Implement Sci 2018;13:80. 10.1186/s13012-018-0758-129879986
NHS. Pay Rates in Local Government. URL: www.healthcareers.nhs.uk/working-health/working-public-health/employers-public-health-staff/local-government/pay-rates-local-government (accessed 2 February 2020).
University of York. Grades 1–8R. URL: www.york.ac.uk/admin/hr/pay-and-grading/pay-scales/grades-1-8/ (accessed 2 February 2020).
Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487–96. 10.1002/hec.94415497198
Community and Mental Health team, NHS Digital. Psychological Therapies: Annual Report on the Use of IAPT Services, England 2018–19. 2019. URL: https://files.digital.nhs.uk/1C/538E29/psych-ther-2018-19-ann-rep.pdf (accessed 3 February 2020).
The Pharmaceutical Journal. Pharmacy Funding Cuts: The Story so Far. URL: www.pharmaceutical-journal.com/news-and-analysis/features/pharmacy-funding-cuts-the-story-so-far/20202223.article?firstPass=false (accessed 3 February 2020).
Kennedy B. Everything You Need to Know About the Pharmacy Cuts. URL: www.chemistanddruggist.co.uk/feature/everything-you-wanted-know-about-funding-cuts (accessed 3 February 2020).
Popp L, Schneider S. Attention placebo control in randomized controlled trials of psychosocial interventions: theory and practice. Trials 2015;16:150. 10.1186/s13063-015-0679-025872619

Attribution. Elizabeth Littlewood; Carolyn A Chew-Graham; Elizabeth Coleman; Samantha Gascoyne; Claire Sloan; Shehzad Ali et al. (2022). A psychological intervention by community pharmacies to prevent depression in adults with subthreshold depression and long-term conditions: the CHEMIST pilot RCT. NIHR Journals Library. Copyright © Queen’s Printer and Controller of HMSO 2022. This work was produced by Littlewood et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. Licensed under CC BY 4.0. NCBI Bookshelf NBK579121. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.